89bio to participate in the piper sandler 32nd annual virtual healthcare conference

San francisco, nov. 24, 2020 (globe newswire) -- 89bio, inc. (nasdaq: etnb), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced that rohan palekar, the company's chief executive officer, will participate in 1x1 meetings with investors at the piper sandler 32nd annual virtual healthcare conference on wednesday, december 2, 2020. the conference will take place december 1-3, 2020. an archived webcast of the fireside chat is accessible in the investor section of 89bio's website.
ETNB Ratings Summary
ETNB Quant Ranking